Stay updated on Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The modernization of the ClinicalTrials.gov data ingest has been postponed to July 2025, and the expected duration of the treatment has been extended from approximately 60 months to 62 months. Additionally, the registry identifiers have been updated.
    Difference
    3%
    Check dated 2025-06-20T06:44:26.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.0%
    Check dated 2025-06-13T01:02:55.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T21:12:31.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.7%
    Check dated 2025-05-29T16:20:36.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T03:46:04.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page has been updated to include new identifiers related to the study of pembrolizumab for squamous cell carcinoma, while significant details about the study's design and criteria have been removed.
    Difference
    15%
    Check dated 2025-04-16T14:26:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.